Interestingly, hepatic expression of HSD17B13 was 5.9 times higher in NASH patients, although HSD17B13 genotype (rs6834314 or rs72613567) did not affect hepatic expression [23]. Here, HSD17B13 is linked to metabolic dysfunction-associated steatohepatitis.